|
KURSLAR, KONFERANSLAR, BİLİMSEL YAYINLAR, BİLDİRİLER VE POSTERLER LİSTESİ
AKADEMİK ATAMALAR
♦ 1981 Instructor in Internal Medicine Michigan StateUniversity, College of Human medicine East Lansing, Michigan; ABD
♦ 1991 Assistant Professor of Medicine Medical Collegeof Georgia Augusta, Georgia; ABD
♦ 1995 Associate Professor of Medicine Medical Collage of Georgia Augusta, Georgia; ABD
♦ 1997 Profesör Ege.Üniversitesi Tıp Fakültesi İç Hastalıkları Ana Bilim Dalı Onkoloji Bilim Dalı Başkanı, İZMİR
♦ 1999 Associate Professor University of Florida Shands Jacksonville, ABD
ÜYESİ OLDUĞU MESLEKİ KURULUŞLAR
♦ 1992-1997 American Cancer Society, Augusta Chapter (ACS)
♦ 1987-1997 American College of Physicians(FACP)
♦ 1985- American Society of Clinical Oncology (ASCO)
♦ 1996-1997 American Society of Hematology (ASH)
♦ 1995- American Medical Association (AMA)
♦ 2000- Duval County MedicalSociety
TEZLER
♦ Granülomatöz hepatit’in teşhisinde semptom, fizik ve laboratuar bulgularının rolü (İç Hastalıkları İhtisas Tezi-1976)
♦ Romatoit artritli hastalarda trombosit antikoru incelenmesi ve bu antikorların trombosit fonksiyonu, klinik ve laboratuar bulguları ile ilişkisi
(İç Hastalıkları Doçentlik Tezi-1982)
VERDİĞİ KONUŞMA VE KONFERANSLAR
♦ University of Florida HealthSciences Center, Grand Rounds: “Targeted Biological Therapy of Cancer (Monoclonal Antibodies)” Jacksonville, Florida, Ocak 2001.
♦ Sixth Annual Multidisciplinary Symposium on Breast Cancer: “Meet the Professor Luncheon Session”. Adjuvant Systemic Therapy, Amelia Island, Florida,Şubat 2001.
♦ The 7th International Adjuvant Therapy of Primary Breast Cancer Conference, Eli Lilly Satellite Symposium: “Combination of Gemzar and Vinorelbine in Advanced Breast Carcinoma”. St Gallen, İsviçre, Şubat 2001.
♦ Yedinci Ulusal Meme HastalıklarıKongresi. “Meme Kanserinin Biolojik Tedavisindeki Yeni Gelişmeler”. Antalya, Turkiye. Ekim 2003.
♦ Genentech Integrated Education (GENIE) Speakers Bureau: “The Management of HER-2 Positive Metastatic Breast Cancer: The Role of Herceptin”. Waycross, Georgia. Ağustos 26, 2004.
♦ Tıbbı Onkoloji Uzmanlık Öğrencileri Eğitim Programı-2. “Kemoprevansiyon”. Ankara, Turkiye. 6-7 Mart 2010.
MAKALELER:
♦ Ege B Derahşan M, Kerse I, Sanal S.
♦ Clinical, laboratory, microscopic and electron micrascopic study of
♦ pseudoxanthoma elasticum.
♦ Acta medica Turcica 8: 3-28, 1972.
♦ Tekdogan M, Sanal S.
♦ Bronkopleural fıstül ile komplike bir ampiyem vakasının tedavisi.
♦ Hacettepe Tıp -Cerrahi Bülteni 5: 151-157,1972.
♦ Sanal SM, Campbel EW, Bowdler AJ, Brat JP.
♦ Pseudoleukemia.
♦ Postgrad Med 65: 143-145, 1979.
♦ Campbell E, Sanal S, Mattson J, Walker L, Estry S, Mueller L, Schwarz M,
♦ Hampton S.
♦ Factor VII inhibitor.
♦ Amer J Med. 68: 962-964, 1980.
♦ Sanal SM, Winiarski NB, Cardenas FJ.
♦ Crohn’s disease with bone marrow granulomas.
♦ South Med J 85: 646-647, 1992.
♦ Sanal SM, Gur-Lavi M.
♦ Reversible bone marrow aplasia induced by naproxen.
♦ Ann Hematol 65: 59-60, 1992.
♦ Sanal SM, Flickinger FW, Caudell MJ, Sherry RM.
♦ Detection of marrow involvement in breast cancer with magnetic resonance
♦ imaging.
♦ J Clin Oncol 12: 1415-1421,1994.
♦ Flickenger FW, Sanal SM.
♦ Bone marrow MRI: techniques and accuracy for detecting breast cancer
♦ metastasis.
♦ Magnetic Resonance Imaging 12 (6): 829-835,1994.
♦ Sanal SM, YaylacıM, Mangold KA, Pantazis CG.
Extensive extramedullary disease in myeloma: an uncommon variant with features
of poor prognosis and dedifferentiation.
♦ Cancer 77: 1298-1302, 1996.
♦ DavisLS, Sanal SM, Sangueza OP.
♦ Treatment of scleromyxedema with 2-chlorodeoxyadenosine.
♦ J Am Acad Dermatol 35: 288-290, 1996.
♦ Gökmen E, Sanal S.
Management of advanced bladder cancer.
Proceedıngs of the Second Balkan Congress of Oncology 143-148, 1998.
♦ Sanal S, Sanlı U, Gökmen E.
Prognostıc factors in breast cancer.
Proceedıngs of the Second Balkan Congress of Oncology 207-214, 1998.
♦ Sanal SM, Gokmen E, Karabulut B, Sezgin C.
Gemcitabine and vinorelbine combination in patients with metastatic breast cancer
♦ The Breast Journal 8: 171-176, 2001.
♦ Goksel T, Hatipoglu O, Ozturk C, Gorguner A M, Kiyik M, Yimaz U, Guzelant A, Tasbakan MS, Tabakoglu E, Firat H, Tutar U, Cikrikcioglu S, Akkoclu A, Soyer S, Cakir E, Itil O, Sanal S.
A prospective, multicenter clinical trial comparing cisplatin plus gemcitabine with cisplatin plus etoposide in locally advanced and metastatic non-small cell lung cancer patients.
Respirology 10: 456-463, 2005
♦ Sanal SM, Sivrikoz ON, Karapolat I, Karademir S
Squamous cell carcinoma of the rectum with liver metastasis: PET/CT demonstrates complete clinical response.
J Clin Oncol(yayına Kabuledildi)
BİLDİRİLER:
♦ Campbell E, Sanal S,Mattson J, Walker L, Estry S, Mueller L, Schwarz M,
♦ Hampton S.
♦ Factor VII inhibitor.
♦ 3 rd Meeting of the Mediterranean Blood Club 3: 26, 1979.
♦ Mattson JC, Sanal SM.
♦ Hairy cell leukemia: report of a case with a plasma mediated defect in platelet
♦ function and platelet morphology.
♦ Thrombos Haemostas 46(1): 422 (Abstr # 1346), 1981.
♦ Sanal SM, Gur - Lavi M.
♦ Reversible bone marrow aplasia induced by naproxen.
♦ Georgia Rheumatism Society (Abstr # 17), 1987.
♦ Sanal SM, Flickinger FW, Caudell MJ, Sherry RM.
♦ Magnetic resonance imaging (MRI) of the bone marrow in breast cancer patients.
♦ Proc Am Soc Clin Oncol 15: 540 (Abstr # 136), 1992.
♦ DiPiro CV. Sanal SM, Harkness KH, Sherry RM, DiPiro JT.
♦ The antiemetic efficacy of intravenous ondansetron at conventional versus low
♦ dose in women with early stage breast cancer.
♦ Proc Am Soc Clin Oncol 15: 540 (Abstr # 1752), 1996.
♦ Steinsapir J, Sanal S.
♦ Clinical and histologic features in thymoma: a report from a single institution
♦ experience.
♦ ACP; Georgia Associates Scientific Meeting (Abstr # 32), 1996 (Poster takdimi).
♦ Sanal SM, Flickinger FW, Litaker MS, Sherry RM.
Abnormal magnetic resonance imaging of bone marrow in patients with operable breast cancer indcates early recurrence and poor survival.
♦ 19 th Annual San Antonio Breast Cancer Symposium (Abstr # 110), 1996 (Poster Takdimi).
♦ Breast Canc 41(3): 228, 1996.
♦ Çekin A.H, Dainer P.M, Kutlar A, Sanal SM.
♦ Haıry Leukemıa (HCL) Wıth Unusual Clınıcal Features; Perıpheral
♦ Lymphadenopaty (LAP), Assocıated Immunoblastıc Lymphoma, and Bılateral
♦ Breast Masses (Abstr # 4080)
♦ Blood 90: (suppl 1) 296b, 1997.
♦ Plouffe JR., L, Trott EA, Sanal S. Sherry RM, Stewart K, Hansen KA,
Sertaline (Zoloft) For The Management of Hot Flashes ın Women on Tamoxıfen : A Randomızed Controlled Pılot Trıal
♦ Menopause 4(4): 262p, 1997 (poster 29).
♦ Gokmen E, Karabulut B, Sezgin C, Sanal S.
A phase II study of gemcitabine and vinorelbine in patients with advanced breast cancer.
Proc Am Soc Clin Oncol19: 110a, 2000 (abstr # 427; poster F3).
♦ Guthrie T, Sanal S, Agaliotis D, Cristea M, Khan W, Swisschuck P.
Hepatic artery chemoembolization with irinotecan for primary and metastatic liver cancer; Preliminary results
Proc Am Soc Clin Oncol19: 305a, 2000 (abstr # 1204).
♦ Sanal SA, Hanson MJ, Dees M, Sylvester L, Sullivan W, Marsland T, Shah S, Guthrie TH: Rituximab induces high response rate and prolonged remission in chronic idiopathic thrombocytopenic purpura: A retrospective analysis.
Blood104(11), 2004 (abstr # 830)
♦ Gökmen E, Sezgin C, Karabulut B, Vazquez A, Sanal S: Gemcitabine plus vinorelbine as first line treatment of metastatic breast cancer. Proc Am Soc Clin Oncol 23: 85s 2005 (abstr # 830).
KİTAP BÖLÜMÜ:
♦ Sanal S, Gokmen E.: Oncoloji; Hasta Örnekleriyle Dahili Bilimler, 795-831;
Ed. Candeğer Yılmaz, Izmir Güven Kitabevi 2002.
|
